| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | MEDTRONIC PLC | 588,299 | 39,381,000 | 0.40% | ||
| 52 | CHIMERIX INC | 1,021,600 | 39,025,000 | 0.39% | ||
| 53 | LOXO ONCOLOGY INC COM | 2,175,857 | 38,034,000 | 0.38% | ||
| 54 | INFINITY PHARMACEUTICALS INC | 4,416,300 | 37,318,000 | 0.38% | ||
| 55 | ACHILLION PHARMACEUTICALS IN | 5,222,500 | 36,087,000 | 0.36% | ||
| 56 | IMMUNOGEN INC | 3,594,000 | 34,502,000 | 0.35% | ||
| 57 | GW PHARMACEUTICALS PLC | 377,100 | 34,456,000 | 0.35% | ||
| 58 | EXACT SCIENCES CORP | 1,778,000 | 31,986,000 | 0.32% | ||
| 59 | SIENTRA INC | 2,980,000 | 30,247,000 | 0.31% | ||
| 60 | CERUS CORP | 6,504,400 | 29,530,000 | 0.30% | ||
| 61 | VALEANT PHARMACEUTICALS INTL | 165,000 | 29,433,000 | 0.30% | ||
| 62 | AFFIMED N V COM | 4,582,616 | 28,275,000 | 0.29% | ||
| 63 | UNITEDHEALTH GROUP INC | 238,000 | 27,610,000 | 0.28% | ||
| 64 | JOHNSON & JOHNSON | 292,000 | 27,258,000 | 0.28% | ||
| 65 | ProQR Therapeutics NV | 1,841,400 | 26,829,000 | 0.27% | ||
| 66 | NEWLINK GENETICS CORP COM | 712,306 | 25,529,000 | 0.26% | ||
| 67 | FORWARD PHARMA A/S | 960,600 | 22,632,000 | 0.23% | ||
| 68 | DYAX CORP COM CVR | 1,117,000 | 21,324,000 | 0.22% | ||
| 69 | GALAPAGOS NV | 512,900 | 20,880,000 | 0.21% | ||
| 70 | ADURO BIOTECH INC | 1,065,522 | 20,639,000 | 0.21% | ||
| 71 | MERCK & CO INC | 415,000 | 20,497,000 | 0.21% | ||
| 72 | XENOPORT INC | 5,768,400 | 20,016,000 | 0.20% | ||
| 73 | ZIMMER BIOMET HLDGS INC | 212,300 | 19,941,000 | 0.20% | ||
| 74 | FLUIDIGM CORP DEL COM | 2,449,900 | 19,869,000 | 0.20% | ||
| 75 | BIOMARIN PHARMACEUTICAL INC | 188,000 | 19,800,000 | 0.20% | ||
| 76 | STRYKER CORP | 186,000 | 17,503,000 | 0.18% | ||
| 77 | EHEALTH INC COM | 1,300,000 | 16,653,000 | 0.17% | ||
| 78 | JAZZ PHARMACEUTICALS PLC | 115,000 | 15,273,000 | 0.15% | ||
| 79 | HEALTH NET INC | 250,000 | 15,055,000 | 0.15% | Call | |
| 80 | Natera, Inc. | 1,276,190 | 13,847,000 | 0.14% | ||
| 81 | XENCOR INC COM | 1,130,022 | 13,820,000 | 0.14% | ||
| 82 | SINOVAC BIOTECH LTD | 2,667,500 | 13,551,000 | 0.14% | ||
| 83 | ASSEMBLY BIOSCIENCES INC | 1,397,100 | 13,356,000 | 0.13% | ||
| 84 | Pieris Pharmaceuticals | 7,259,620 | 13,285,000 | 0.13% | ||
| 85 | ADR - Nabriva Therapeutics AG- Usd | 1,315,000 | 12,493,000 | 0.13% | ||
| 86 | SYNERGY PHARMACEUTICALS DEL | 2,276,648 | 12,066,000 | 0.12% | ||
| 87 | VERTEX PHARMACEUTICALS INC | 115,000 | 11,976,000 | 0.12% | ||
| 88 | CARDINAL HEALTH INC | 146,000 | 11,216,000 | 0.11% | ||
| 89 | ENSIGN GROUP INC | 247,600 | 10,555,000 | 0.11% | ||
| 90 | BAXTER INTL INC | 319,000 | 10,479,000 | 0.11% | ||
| 91 | WELLCARE HEALTH PLANS INC | 114,000 | 9,825,000 | 0.10% | ||
| 92 | INCYTE CORP | 4,250,000 | 9,403,000 | 0.10% | PRN | |
| 93 | CELLECTIS S A | 350,000 | 9,226,000 | 0.09% | ||
| 94 | BAXALTA INC COM | 285,000 | 8,980,000 | 0.09% | ||
| 95 | INCYTE CORP SR CV NT0.375 18 | 4,250,000 | 8,979,000 | 0.09% | PRN | |
| 96 | ABBOTT LABS | 211,000 | 8,486,000 | 0.09% | ||
| 97 | MIRATI THERAPEUTICS INC COM | 240,000 | 8,261,000 | 0.08% | ||
| 98 | CONNECTURE INC | 1,740,000 | 7,934,000 | 0.08% | ||
| 99 | CYNAPSUS THERAPEUTICS INC | 487,000 | 7,875,000 | 0.08% | ||
| 100 | AETNA INC NEW | 67,000 | 7,330,000 | 0.07% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-001946, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
